Global Biologic Therapeutics Drugs Market Growth 2021-2026

Publisher Name :
Date: 22-Feb-2021
No. of pages: 130

According to this latest study, the 2020 growth of Biologic Therapeutics Drugs will have significant change from previous year. By the most conservative estimates of global Biologic Therapeutics Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 315410 million in 2019. Over the next five years the Biologic Therapeutics Drugs market will register a 6.2% CAGR in terms of revenue, the global market size will reach US$ 401730 million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Biologic Therapeutics Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.

- Humans

- Avian Cell Culture

- Yeast

- Bacteria

- Insects Cell Culture

- Transgenics

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.

- Rheumatoid Arthritis

- Anemia

- Cancer

- Diabetes

- Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.

- Pfizer

- AstraZeneca

- Novartis

- Merck

- Smith Medical

- GlaxoSmithKline

- Concord Biotech

- Aurobindo Pharma

- H. Lundbeck

- Retractable Technologies

Global Biologic Therapeutics Drugs Market Growth 2021-2026

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Biologic Therapeutics Drugs Consumption 2016-2026
2.1.2 Biologic Therapeutics Drugs Consumption CAGR by Region
2.2 Biologic Therapeutics Drugs Segment by Type
2.2.1 Humans
2.2.2 Avian Cell Culture
2.2.3 Yeast
2.2.4 Bacteria
2.2.5 Insects Cell Culture
2.2.6 Transgenics
2.3 Biologic Therapeutics Drugs Sales by Type
2.3.1 Global Biologic Therapeutics Drugs Sales Market Share by Type (2016-2021)
2.3.2 Global Biologic Therapeutics Drugs Revenue and Market Share by Type (2016-2021)
2.3.3 Global Biologic Therapeutics Drugs Sale Price by Type (2016-2021)
2.4 Biologic Therapeutics Drugs Segment by Application
2.4.1 Rheumatoid Arthritis
2.4.2 Anemia
2.4.3 Cancer
2.4.4 Diabetes
2.4.5 Others
2.5 Biologic Therapeutics Drugs Sales by Application
2.5.1 Global Biologic Therapeutics Drugs Sale Market Share by Application (2016-2021)
2.5.2 Global Biologic Therapeutics Drugs Revenue and Market Share by Application (2016-2021)
2.5.3 Global Biologic Therapeutics Drugs Sale Price by Application (2016-2021)

3 Global Biologic Therapeutics Drugs by Company
3.1 Global Biologic Therapeutics Drugs Sales Market Share by Company
3.1.1 Global Biologic Therapeutics Drugs Sales by Company (2019-2021)
3.1.2 Global Biologic Therapeutics Drugs Sales Market Share by Company (2019-2021)
3.2 Global Biologic Therapeutics Drugs Revenue Market Share by Company
3.2.1 Global Biologic Therapeutics Drugs Revenue by Company (2019-2021)
3.2.2 Global Biologic Therapeutics Drugs Revenue Market Share by Company (2019-2021)
3.3 Global Biologic Therapeutics Drugs Sale Price by Company
3.4 Global Manufacturers Biologic Therapeutics Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Biologic Therapeutics Drugs Product Location Distribution
3.4.2 Players Biologic Therapeutics Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Biologic Therapeutics Drugs by Region
4.1 Global Biologic Therapeutics Drugs by Region
4.1.1 Global Biologic Therapeutics Drugs Sales by Region
4.1.2 Global Biologic Therapeutics Drugs Revenue by Region
4.2 Americas Biologic Therapeutics Drugs Sales Growth
4.3 APAC Biologic Therapeutics Drugs Sales Growth
4.4 Europe Biologic Therapeutics Drugs Sales Growth
4.5 Middle East & Africa Biologic Therapeutics Drugs Sales Growth

5 Americas
5.1 Americas Biologic Therapeutics Drugs Sales by Country
5.1.1 Americas Biologic Therapeutics Drugs Sales by Country (2016-2021)
5.1.2 Americas Biologic Therapeutics Drugs Revenue by Country (2016-2021)
5.2 Americas Biologic Therapeutics Drugs Sales by Type
5.3 Americas Biologic Therapeutics Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Biologic Therapeutics Drugs Sales by Region
6.1.1 APAC Biologic Therapeutics Drugs Sales by Region (2016-2021)
6.1.2 APAC Biologic Therapeutics Drugs Revenue by Region (2016-2021)
6.2 APAC Biologic Therapeutics Drugs Sales by Type
6.3 APAC Biologic Therapeutics Drugs Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Biologic Therapeutics Drugs by Country
7.1.1 Europe Biologic Therapeutics Drugs Sales by Country (2016-2021)
7.1.2 Europe Biologic Therapeutics Drugs Revenue by Country (2016-2021)
7.2 Europe Biologic Therapeutics Drugs Sales by Type
7.3 Europe Biologic Therapeutics Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Biologic Therapeutics Drugs by Country
8.1.1 Middle East & Africa Biologic Therapeutics Drugs Sales by Country (2016-2021)
8.1.2 Middle East & Africa Biologic Therapeutics Drugs Revenue by Country (2016-2021)
8.2 Middle East & Africa Biologic Therapeutics Drugs Sales by Type
8.3 Middle East & Africa Biologic Therapeutics Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Biologic Therapeutics Drugs Distributors
10.3 Biologic Therapeutics Drugs Customer

11 Global Biologic Therapeutics Drugs Market Forecast
11.1 Global Biologic Therapeutics Drugs Forecast by Region
11.1.1 Global Biologic Therapeutics Drugs Forecast by Regions (2021-2026)
11.2.2 Global Biologic Therapeutics Drugs Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Biologic Therapeutics Drugs Forecast by Type
11.7 Global Biologic Therapeutics Drugs Forecast by Application

12 Key Players Analysis
12.1 Pfizer
12.1.1 Pfizer Pfizer Company Information
12.1.2 Pfizer Biologic Therapeutics Drugs Product Offered
12.1.3 Pfizer Biologic Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Pfizer Main Business Overview
12.1.5 Pfizer Latest Developments
12.2 AstraZeneca
12.2.1 AstraZeneca Company Information
12.2.2 AstraZeneca Biologic Therapeutics Drugs Product Offered
12.2.3 AstraZeneca Biologic Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 AstraZeneca Main Business Overview
12.2.5 AstraZeneca Latest Developments
12.3 Novartis
12.3.1 Novartis Company Information
12.3.2 Novartis Biologic Therapeutics Drugs Product Offered
12.3.3 Novartis Biologic Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Novartis Main Business Overview
12.3.5 Novartis Latest Developments
12.4 Merck
12.4.1 Merck Company Information
12.4.2 Merck Biologic Therapeutics Drugs Product Offered
12.4.3 Merck Biologic Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Merck Main Business Overview
12.4.5 Merck Latest Developments
12.5 Smith Medical
12.5.1 Smith Medical Company Information
12.5.2 Smith Medical Biologic Therapeutics Drugs Product Offered
12.5.3 Smith Medical Biologic Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Smith Medical Main Business Overview
12.5.5 Smith Medical Latest Developments
12.6 GlaxoSmithKline
12.6.1 GlaxoSmithKline Company Information
12.6.2 GlaxoSmithKline Biologic Therapeutics Drugs Product Offered
12.6.3 GlaxoSmithKline Biologic Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 GlaxoSmithKline Main Business Overview
12.6.5 GlaxoSmithKline Latest Developments
12.7 Concord Biotech
12.7.1 Concord Biotech Company Information
12.7.2 Concord Biotech Biologic Therapeutics Drugs Product Offered
12.7.3 Concord Biotech Biologic Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Concord Biotech Main Business Overview
12.7.5 Concord Biotech Latest Developments
12.8 Aurobindo Pharma
12.8.1 Aurobindo Pharma Company Information
12.8.2 Aurobindo Pharma Biologic Therapeutics Drugs Product Offered
12.8.3 Aurobindo Pharma Biologic Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Aurobindo Pharma Main Business Overview
12.8.5 Aurobindo Pharma Latest Developments
12.9 H. Lundbeck
12.9.1 H. Lundbeck Company Information
12.9.2 H. Lundbeck Biologic Therapeutics Drugs Product Offered
12.9.3 H. Lundbeck Biologic Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 H. Lundbeck Main Business Overview
12.9.5 H. Lundbeck Latest Developments
12.10 Retractable Technologies
12.10.1 Retractable Technologies Company Information
12.10.2 Retractable Technologies Biologic Therapeutics Drugs Product Offered
12.10.3 Retractable Technologies Biologic Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Retractable Technologies Main Business Overview
12.10.5 Retractable Technologies Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Biologic Therapeutics Drugs Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Humans
Table 3. Major Players of Avian Cell Culture
Table 4. Major Players of Yeast
Table 5. Major Players of Bacteria
Table 6. Major Players of Insects Cell Culture
Table 7. Major Players of Transgenics
Table 8. Global Biologic Therapeutics Drugs Sales by Type (2016-2021) & (MT)
Table 9. Global Biologic Therapeutics Drugs Sales Market Share by Type (2016-2021)
Table 10. Global Biologic Therapeutics Drugs Revenue by Type (2016-2021) & ($ million)
Table 11. Global Biologic Therapeutics Drugs Revenue Market Share by Type (2016-2021)
Table 12. Global Biologic Therapeutics Drugs Sale Price by Type (2016-2021)
Table 13. Global Biologic Therapeutics Drugs Sales by Application (2016-2021) & (MT)
Table 14. Global Biologic Therapeutics Drugs Sales Market Share by Application (2016-2021)
Table 15. Global Biologic Therapeutics Drugs Value by Application (2016-2021)
Table 16. Global Biologic Therapeutics Drugs Revenue Market Share by Application (2016-2021)
Table 17. Global Biologic Therapeutics Drugs Sale Price by Application (2016-2021)
Table 18. Global Biologic Therapeutics Drugs Sales by Company (2019-2021) & (MT)
Table 19. Global Biologic Therapeutics Drugs Sales Market Share by Company (2019-2021)
Table 20. Global Biologic Therapeutics Drugs Revenue by Company (2019-2021) ($ Millions)
Table 21. Global Biologic Therapeutics Drugs Revenue Market Share by Company (2019-2021)
Table 22. Global Biologic Therapeutics Drugs Sale Price by Company (2019-2021)
Table 23. Key Manufacturers Biologic Therapeutics Drugs Producing Area Distribution and Sales Area
Table 24. Players Biologic Therapeutics Drugs Products Offered
Table 25. Biologic Therapeutics Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Biologic Therapeutics Drugs Sales by Region (2016-2021) (MT)
Table 29. Global Biologic Therapeutics Drugs Sales Market Share by Region (2016-2021)
Table 30. Global Biologic Therapeutics Drugs Revenue by Region (2016-2021) & ($ Millions)
Table 31. Global Biologic Therapeutics Drugs Revenue Market Share by Region (2016-2021)
Table 32. Americas Biologic Therapeutics Drugs Sales by Country (2016-2021) & (MT)
Table 33. Americas Biologic Therapeutics Drugs Sales Market Share by Country (2016-2021)
Table 34. Americas Biologic Therapeutics Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 35. Americas Biologic Therapeutics Drugs Revenue Market Share by Country (2016-2021)
Table 36. Americas Biologic Therapeutics Drugs Sales by Type (2016-2021) & (MT)
Table 37. Americas Biologic Therapeutics Drugs Sales Market Share by Type (2016-2021)
Table 38. Americas Biologic Therapeutics Drugs Sales by Application (2016-2021) & (MT)
Table 39. Americas Biologic Therapeutics Drugs Sales Market Share by Application (2016-2021)
Table 40. APAC Biologic Therapeutics Drugs Sales by Region (2016-2021) & (MT)
Table 41. APAC Biologic Therapeutics Drugs Sales Market Share by Region (2016-2021)
Table 42. APAC Biologic Therapeutics Drugs Revenue by Region (2016-2021) & ($ Millions)
Table 43. APAC Biologic Therapeutics Drugs Revenue Market Share by Region (2016-2021)
Table 44. APAC Biologic Therapeutics Drugs Sales by Type (2016-2021) & (MT)
Table 45. APAC Biologic Therapeutics Drugs Sales Market Share by Type (2016-2021)
Table 46. APAC Biologic Therapeutics Drugs Sales by Application (2016-2021) & (MT)
Table 47. APAC Biologic Therapeutics Drugs Sales Market Share by Application (2016-2021)
Table 48. Europe Biologic Therapeutics Drugs Sales by Country (2016-2021) & (MT)
Table 49. Europe Biologic Therapeutics Drugs Sales Market Share by Country (2016-2021)
Table 50. Europe Biologic Therapeutics Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 51. Europe Biologic Therapeutics Drugs Revenue Market Share by Country (2016-2021)
Table 52. Europe Biologic Therapeutics Drugs Sales by Type (2016-2021) & (MT)
Table 53. Europe Biologic Therapeutics Drugs Sales Market Share by Type (2016-2021)
Table 54. Europe Biologic Therapeutics Drugs Sales by Application (2016-2021) & (MT)
Table 55. Europe Biologic Therapeutics Drugs Sales Market Share by Application (2016-2021)
Table 56. Middle East & Africa Biologic Therapeutics Drugs Sales by Country (2016-2021) & (MT)
Table 57. Middle East & Africa Biologic Therapeutics Drugs Sales Market Share by Country (2016-2021)
Table 58. Middle East & Africa Biologic Therapeutics Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 59. Middle East & Africa Biologic Therapeutics Drugs Revenue Market Share by Country (2016-2021)
Table 60. Middle East & Africa Biologic Therapeutics Drugs Sales by Type (2016-2021) & (MT)
Table 61. Middle East & Africa Biologic Therapeutics Drugs Sales Market Share by Type (2016-2021)
Table 62. Middle East & Africa Biologic Therapeutics Drugs Sales by Application (2016-2021) & (MT)
Table 63. Middle East & Africa Biologic Therapeutics Drugs Sales Market Share by Application (2016-2021)
Table 64. Global Biologic Therapeutics Drugs Sales Forecast by Type (2021-2026) & (MT)
Table 65. Global Biologic Therapeutics Drugs Sales Market Share Forecast by Type (2021-2026)
Table 66. Global Biologic Therapeutics Drugs Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 67. Global Biologic Therapeutics Drugs Revenue Market Share Forecast by Type (2021-2026)
Table 68. Global Biologic Therapeutics Drugs Sales Forecast by Application (2021-2026) & (MT)
Table 69. Global Biologic Therapeutics Drugs Sales Market Share Forecast by Application (2021-2026)
Table 70. Global Biologic Therapeutics Drugs Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 71. Global Biologic Therapeutics Drugs Revenue Market Share Forecast by Application (2021-2026)
Table 72. Pfizer Basic Information, Biologic Therapeutics Drugs Manufacturing Base, Sales Area and Its Competitors
Table 73. Pfizer Biologic Therapeutics Drugs Product Offered
Table 74. Pfizer Biologic Therapeutics Drugs Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 75. Pfizer Main Business
Table 76. Pfizer Latest Developments
Table 77. AstraZeneca Basic Information, Biologic Therapeutics Drugs Manufacturing Base, Sales Area and Its Competitors
Table 78. AstraZeneca Biologic Therapeutics Drugs Product Offered
Table 79. AstraZeneca Biologic Therapeutics Drugs Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 80. AstraZeneca Main Business
Table 81. AstraZeneca Latest Developments
Table 82. Novartis Basic Information, Biologic Therapeutics Drugs Manufacturing Base, Sales Area and Its Competitors
Table 83. Novartis Biologic Therapeutics Drugs Product Offered
Table 84. Novartis Biologic Therapeutics Drugs Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 85. Novartis Main Business
Table 86. Novartis Latest Developments
Table 87. Merck Basic Information, Biologic Therapeutics Drugs Manufacturing Base, Sales Area and Its Competitors
Table 88. Merck Biologic Therapeutics Drugs Product Offered
Table 89. Merck Biologic Therapeutics Drugs Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 90. Merck Main Business
Table 91. Merck Latest Developments
Table 92. Smith Medical Basic Information, Biologic Therapeutics Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. Smith Medical Biologic Therapeutics Drugs Product Offered
Table 94. Smith Medical Biologic Therapeutics Drugs Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 95. Smith Medical Main Business
Table 96. Smith Medical Latest Developments
Table 97. GlaxoSmithKline Basic Information, Biologic Therapeutics Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. GlaxoSmithKline Biologic Therapeutics Drugs Product Offered
Table 99. GlaxoSmithKline Biologic Therapeutics Drugs Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 100. GlaxoSmithKline Main Business
Table 101. GlaxoSmithKline Latest Developments
Table 102. Concord Biotech Basic Information, Biologic Therapeutics Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. Concord Biotech Biologic Therapeutics Drugs Product Offered
Table 104. Concord Biotech Biologic Therapeutics Drugs Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 105. Concord Biotech Main Business
Table 106. Concord Biotech Latest Developments
Table 107. Aurobindo Pharma Basic Information, Biologic Therapeutics Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. Aurobindo Pharma Biologic Therapeutics Drugs Product Offered
Table 109. Aurobindo Pharma Biologic Therapeutics Drugs Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 110. Aurobindo Pharma Main Business
Table 111. Aurobindo Pharma Latest Developments
Table 112. H. Lundbeck Basic Information, Biologic Therapeutics Drugs Manufacturing Base, Sales Area and Its Competitors
Table 113. H. Lundbeck Biologic Therapeutics Drugs Product Offered
Table 114. H. Lundbeck Biologic Therapeutics Drugs Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 115. H. Lundbeck Main Business
Table 116. H. Lundbeck Latest Developments
Table 117. Retractable Technologies Basic Information, Biologic Therapeutics Drugs Manufacturing Base, Sales Area and Its Competitors
Table 118. Retractable Technologies Biologic Therapeutics Drugs Product Offered
Table 119. Retractable Technologies Biologic Therapeutics Drugs Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 120. Retractable Technologies Main Business
Table 121. Retractable Technologies Latest Developments
List of Figures
Figure 1. Picture of Biologic Therapeutics Drugs
Figure 2. Biologic Therapeutics Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Biologic Therapeutics Drugs Sales Growth Rate 2016-2026 (MT)
Figure 7. Global Biologic Therapeutics Drugs Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Biologic Therapeutics Drugs Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Humans
Figure 10. Product Picture of Avian Cell Culture
Figure 11. Product Picture of Yeast
Figure 12. Product Picture of Bacteria
Figure 13. Product Picture of Insects Cell Culture
Figure 14. Product Picture of Transgenics
Figure 15. Global Biologic Therapeutics Drugs Sales Market Share by Type in 2020
Figure 16. Global Biologic Therapeutics Drugs Revenue Market Share by Type (2016-2021)
Figure 17. Biologic Therapeutics Drugs Consumed in Rheumatoid Arthritis
Figure 18. Global Biologic Therapeutics Drugs Market: Rheumatoid Arthritis (2016-2021) & (MT)
Figure 19. Biologic Therapeutics Drugs Consumed in Anemia
Figure 20. Global Biologic Therapeutics Drugs Market: Anemia (2016-2021) & (MT)
Figure 21. Biologic Therapeutics Drugs Consumed in Cancer
Figure 22. Global Biologic Therapeutics Drugs Market: Cancer (2016-2021) & (MT)
Figure 23. Biologic Therapeutics Drugs Consumed in Diabetes
Figure 24. Global Biologic Therapeutics Drugs Market: Diabetes (2016-2021) & (MT)
Figure 25. Biologic Therapeutics Drugs Consumed in Others
Figure 26. Global Biologic Therapeutics Drugs Market: Others (2016-2021) & (MT)
Figure 27. Global Biologic Therapeutics Drugs Sales Market Share by Application (2016-2021)
Figure 28. Global Biologic Therapeutics Drugs Revenue Market Share by Application in 2020
Figure 29. Global Biologic Therapeutics Drugs Revenue Market by Company in 2020 ($ Million)
Figure 30. Global Biologic Therapeutics Drugs Revenue Market Share by Company in 2020
Figure 31. Global Biologic Therapeutics Drugs Sales Market Share by Regions (2016-2021)
Figure 32. Global Biologic Therapeutics Drugs Revenue Market Share by Region in 2020
Figure 33. Americas Biologic Therapeutics Drugs Sales 2016-2021 (MT)
Figure 34. Americas Biologic Therapeutics Drugs Revenue 2016-2021 ($ Millions)
Figure 35. APAC Biologic Therapeutics Drugs Sales 2016-2021 (MT)
Figure 36. APAC Biologic Therapeutics Drugs Revenue 2016-2021 ($ Millions)
Figure 37. Europe Biologic Therapeutics Drugs Sales 2016-2021 (MT)
Figure 38. Europe Biologic Therapeutics Drugs Revenue 2016-2021 ($ Millions)
Figure 39. Middle East & Africa Biologic Therapeutics Drugs Sales 2016-2021 (MT)
Figure 40. Middle East & Africa Biologic Therapeutics Drugs Revenue 2016-2021 ($ Millions)
Figure 41. Americas Biologic Therapeutics Drugs Sales Market Share by Country in 2020
Figure 42. Americas Biologic Therapeutics Drugs Revenue Market Share by Country in 2020
Figure 43. Americas Biologic Therapeutics Drugs Sales Market Share by Type in 2020
Figure 44. Americas Biologic Therapeutics Drugs Sales Market Share by Application in 2020
Figure 45. United States Biologic Therapeutics Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 46. Canada Biologic Therapeutics Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 47. Mexico Biologic Therapeutics Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 48. Brazil Biologic Therapeutics Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 49. APAC Biologic Therapeutics Drugs Sales Market Share by Region in 2020
Figure 50. APAC Biologic Therapeutics Drugs Revenue Market Share by Regions in 2020
Figure 51. APAC Biologic Therapeutics Drugs Sales Market Share by Type in 2020
Figure 52. APAC Biologic Therapeutics Drugs Sales Market Share by Application in 2020
Figure 53. China Biologic Therapeutics Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 54. Japan Biologic Therapeutics Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 55. Korea Biologic Therapeutics Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 56. Southeast Asia Biologic Therapeutics Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 57. India Biologic Therapeutics Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 58. Australia Biologic Therapeutics Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 59. Europe Biologic Therapeutics Drugs Sales Market Share by Country in 2020
Figure 60. Europe Biologic Therapeutics Drugs Revenue Market Share by Country in 2020
Figure 61. Europe Biologic Therapeutics Drugs Sales Market Share by Type in 2020
Figure 62. Europe Biologic Therapeutics Drugs Sales Market Share by Application in 2020
Figure 63. Germany Biologic Therapeutics Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 64. France Biologic Therapeutics Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 65. UK Biologic Therapeutics Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 66. Italy Biologic Therapeutics Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 67. Russia Biologic Therapeutics Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 68. Middle East & Africa Biologic Therapeutics Drugs Sales Market Share by Country in 2020
Figure 69. Middle East & Africa Biologic Therapeutics Drugs Revenue Market Share by Country in 2020
Figure 70. Middle East & Africa Biologic Therapeutics Drugs Sales Market Share by Type in 2020
Figure 71. Middle East & Africa Biologic Therapeutics Drugs Sales Market Share by Application in 2020
Figure 72. Egypt Biologic Therapeutics Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 73. South Africa Biologic Therapeutics Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 74. Israel Biologic Therapeutics Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 75. Turkey Biologic Therapeutics Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 76. GCC Country Biologic Therapeutics Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 77. Channels of Distribution
Figure 78. Distributors Profiles
  • (Post-pandemic Era) - Global Herbal Oil Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2016-2027
    Published: 26-Feb-2021        Price: US 3650 Onwards        Pages: 118
    Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly opt......
  • Post-pandemic Era - Global Herbal Oil Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 26-Feb-2021        Price: US 3620 Onwards        Pages: 112
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • (Post-pandemic Era) - Global Herbal Oil Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
    Published: 26-Feb-2021        Price: US 3160 Onwards        Pages: 97
    Summary At the time of this report, many government announced a plan on reopening the national economy, but many countries are still at the stage of rising. It should be noted that the impact of the epidemic has accelerated the trend of localization, regionalization and decentralization of the global industrial chain and supply chain, so it is inevitable to reconstruct the global industrial chain. Faced with the global industrial change in the post epidemic era, enterprises in var......
  • (Post-pandemic Era) - Global Excipients Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2016-2027
    Published: 26-Feb-2021        Price: US 3650 Onwards        Pages: 105
    Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly opt......
  • Post-pandemic Era - Global Excipients Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 26-Feb-2021        Price: US 3620 Onwards        Pages: 105
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • (Post-pandemic Era) - Global Excipients Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
    Published: 26-Feb-2021        Price: US 3160 Onwards        Pages: 81
    Summary At the time of this report, many government announced a plan on reopening the national economy, but many countries are still at the stage of rising. It should be noted that the impact of the epidemic has accelerated the trend of localization, regionalization and decentralization of the global industrial chain and supply chain, so it is inevitable to reconstruct the global industrial chain. Faced with the global industrial change in the post epidemic era, enterprises in var......
  • (Post-pandemic Era) - Global Cold Chain for Pharmaceutical Market Assessment, With Major Companies Analysis, Regional Analysis, Breakdown Data by Application/Type 2021
    Published: 26-Feb-2021        Price: US 4860 Onwards        Pages: 80
    Summary This study analysis was given on a worldwide scale, for instance, present and historical Cold Chain for Pharmaceutical growth analysis, competitive analysis, and also the growth prospects of the major regions. The report gives an exhaustive investigation of this market at country & regional levels, and provides an analysis of the industry trends in each of the sub-segments, from production, revenue and consumption. A quantitative and qualitative analysis of the main player......
  • (Post-pandemic Era) - Global Cold Chain for Pharmaceutical Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2016-2027
    Published: 26-Feb-2021        Price: US 3650 Onwards        Pages: 103
    Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly opt......
  • Post-pandemic Era - Global Cold Chain for Pharmaceutical Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 26-Feb-2021        Price: US 3620 Onwards        Pages: 103
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs